Easy CDMO is a Leading provider of new drug intermediates, including clinical phase II and III intermediates, GMP custom synthesis, and DMF filling. Easy CDMO holds a prominent position in the industry.

Every year, Easy CDMO synthesizes over 500 fresh compounds, along with a stock of more than 30000 building blocks, and we boast a skillful delivery service that can provide orders on the same day for more than 100000 items.

In China, Easy CDMO is a leading provider of intermediates for cancer, ophthalmology, neurological, rheumatism, and immunity treatments. Our intermediates are produced in-house at our GMP plant, and our site has passed audits for quality and safety. Our DMF is also approved.

Before 2023, Easy CDMO had a research and development team of over 60 individuals, including 20 doctors and 40 masters. Most of the team members possessed over 10 years of experience in drug discovery.

Easy CDMO has the TOP 9 skills in reaction: Flow Chemistry, Fluorination, Asymmetric, Chiral Synthesis, Hazardous, Low Temperature, High-Pressure Chemistry, Electrochemistry, and Photochemistry.